Sponsor or institution
Clinical trials and research at Glaukos Corporation
As of November 12, 2026, Find a Trial lists 11 clinical trials run by Glaukos Corporation that are recruiting, at sites in 4 countries (most in United States (11), Germany (1), Italy (1)). By phase: Phase 2 (4), Phase 4 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 4Countries
Newest trials
All recruiting trials (11)
-
iDose TR implant administration in an office-based eye clinic
This study tests a travoprost implant (iDose TR) given inside the eye to people with open-angle glaucoma or high eye pressure in an office setting to see if it is safe.
-
Same-day bilateral corneal cross-linking for keratoconus
This trial tests whether performing corneal cross-linking in both eyes on the same day is safe and feasible for people with keratoconus.
-
Second-generation travoprost intracameral implant versus timolol drops for open-angle glaucoma
This will test whether a small travoprost implant placed inside the eye can lower eye pressure as well as twice-daily timolol drops in people with open-angle glaucoma or ocular hypertension.
-
GLK-321 eye drops for Demodex blepharitis.
This trial will test whether different doses of GLK-321 eye drops can reduce the signs of Demodex blepharitis in adults with the condition.
-
GLK-221 eye drops for keratoconus
This trial will test whether twice-daily GLK-221 eye drops are safe and help adults aged 18–55 with keratoconus compared with a placebo.
-
Updated inserter for the 75 mcg Travoprost intracameral implant
This study will see if the new G2-TRIO inserter reliably and safely delivers the 75 mcg Travoprost intracameral implant in adults with open-angle glaucoma or ocular hypertension.
-
Second-generation travoprost intracameral implant for open-angle glaucoma and ocular hypertension
This trial will test whether a second-generation travoprost implant placed inside the eye lowers eye pressure better than timolol eye drops in people with open-angle glaucoma or ocular hypertension.
-
Evaluating the safety and effectiveness of iDose TR with cataract surgery
This study is testing if adding the iDose TR implant during cataract surgery can safely lower eye pressure better than just having cataract surgery alone for people with glaucoma or high eye pressure.
-
Comparison of Travoprost Implant with iStent Infinite vs. iStent Infinite Alone for Glaucoma
This study tests if combining a new eye implant with the iStent Infinite can lower eye pressure better than using the iStent Infinite alone in adults with glaucoma or high eye pressure.
-
Treatment for mild to moderate primary open-angle glaucoma using the iStent Infinite device
This study is testing a new device called the iStent Infinite to see if it can help adults with mild to moderate glaucoma who haven't had success with other treatments.
-
Evaluating NEXAGON® for treating persistent corneal epithelial defects
This study is testing if NEXAGON® eye gel can help people with stubborn corneal problems that haven't improved with regular treatments.
Quick answers
How many clinical trials run by Glaukos Corporation are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (11 trials), Germany (1 trial), Italy (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 4: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.